Target Name: MIR636
NCBI ID: G693221
Review Report on MIR636 Target / Biomarker Content of Review Report on MIR636 Target / Biomarker
MIR636
Other Name(s): microRNA 636 | MicroRNA 636 | MIRN636 | hsa-miR-636 | hsa-mir-636

MicroRNA-636: A Non-Coding RNA Molecule Regulating

MicroRNA (miRNA) 636 is a non-coding RNA molecule that plays a crucial role in various cellular processes. It is made up of 202 amino acid residues and has a calculated molecular weight of 21.1 kDa. MIR636 is a part of the miRNA family 18 , which are characterized by a specific stem-loop structure.

MIR636 is involved in various cellular processes, including cell growth, apoptosis, and metabolism. It has been shown to regulate the expression of several target genes, including TGIP3, FKBP14, and UZF1B. TGIP3 is a transduction factor that plays a role in cell signaling, while FKBP14 is a protein that is involved in protein-protein interactions. UZF1B is a non-coding RNA molecule that has been shown to play a role in regulating gene expression.

MIR636 has also been shown to play a role in the regulation of cellular apoptosis. Apoptosis is a natural process that is involved in the elimination of damaged or dysfunctional cells. MIR636 has also been shown to regulate the expression of genes that are involved in the execution of apoptosis. For example, it has been shown to inhibit the expression of genes that are involved in the execution of programmed cell death, such as Bax.

MIR636 has also been shown to play a role in the regulation of cellular metabolism. It has been shown to regulate the expression of genes that are involved in cell metabolism, such as GLUT1 and PPAR未. GLUT1 is a gene that encodes the protein GLUT1, which is involved in glucose uptake and storage. PPAR未 is a gene that encodes the protein PPAR未, which is involved in the regulation of lipid metabolism.

MIR636 has also been shown to play a role in the regulation of cellular signaling pathways. It has been shown to regulate the expression of genes that are involved in various signaling pathways, including TGF-β signaling and NF-kappa-B signaling. TGF-β is a signaling pathway that is involved in the regulation of cell growth and differentiation, while NF-kappa-B is a signaling pathway that is involved in the regulation of inflammation and immune responses.

MIR636 has also been shown to play a role in the regulation of gene expression in cancer cells. It has been shown to regulate the expression of genes that are involved in the development and progression of cancer. For example, it has been shown to inhibit the expression of genes that are involved in the development of cancer by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in neurodegenerative diseases. It has been shown to regulate the expression of genes that are involved in the development and progression of neurodegenerative diseases. For example, it has been shown to inhibit the expression of genes that are involved in the development of neurodegenerative diseases by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with inflammation. It has been shown to regulate the expression of genes that are involved in the development and progression of diseases associated with inflammation. has been shown to inhibit the expression of genes that are involved in the development of diseases associated with inflammation by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in autoimmune diseases. It has been shown to regulate the expression of genes that are involved in the development and progression of autoimmune diseases. For example, it has been shown to inhibit the expression of genes that are involved in the development of autoimmune diseases by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with aging. It has been shown to regulate the expression of genes that are involved in the development and progression of diseases associated with aging. For example, it has has been shown to inhibit the expression of genes that are involved in the development of diseases associated with aging by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with nutrient deficiencies. It has been shown to regulate the expression of genes that are involved in the development and progression of diseases associated with nutrient deficiencies. For example, it has been shown to inhibit the expression of genes that are involved in the development of diseases associated with nutrient deficiencies by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with oxidative stress. It has been shown to regulate the expression of genes that are involved in the development and progression of diseases associated with oxidative stress. For example, it has been shown to inhibit the expression of genes that are involved in the development of diseases associated with oxidative stress by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with inflammation. It has been shown to regulate the expression of genes that are involved in the development and progression of diseases associated with inflammation. has been shown to inhibit the expression of genes that are involved in the development of diseases associated with inflammation by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with cellular stress. It has been shown to regulate the expression of genes that are involved in the development and progression of diseases associated with cellular stress. For example, it has been shown to inhibit the expression of genes that are involved in the development of diseases associated with cellular stress by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with DNA damage. It has been shown to regulate the expression of genes that are involved in the development and progression of diseases associated with DNA damage. For example, it has been shown to inhibit the expression of genes that are involved in the development of diseases associated with DNA damage by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with protein homeostasis. It has been shown to regulate the expression of genes that are involved in the development and progression of diseases associated with protein homeostasis. For example, it has been shown to inhibit the expression of genes that are involved in the development of diseases associated with protein homeostasis by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with cellular signaling pathways. It has been shown to regulate the expression of genes that are involved in various cellular signaling pathways, including TGF-β signaling and NF-kappa-B signaling. TGF-β is a signaling pathway that is involved in the regulation of cell growth and differentiation, while NF-kappa-B is a signaling pathway that is involved in the regulation of inflammation and immune responses.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with inflammation. It has been shown to regulate the expression of genes that are involved in the development and progression of diseases associated with inflammation. has been shown to inhibit the expression of genes that are involved in the development of diseases associated with inflammation by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with neurodegenerative diseases. It has been shown to regulate the expression of genes that are involved in the development and progression of neurodegenerative diseases. For example, it has been shown to inhibit the expression of genes that are involved in the development of neurodegenerative diseases by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with autoimmune diseases. It has been shown to regulate the expression of genes that are involved in the development and progression of autoimmune diseases. For example, it has been shown to inhibit the expression of genes that are involved in the development of autoimmune diseases by promoting the expression of genes that are involved in cell growth and apoptosis.

MIR636 has also been shown to play a role in the regulation of gene expression in diseases associated with aging. It has been shown to regulate the expression of genes that are involved in the development and progression of diseases associated with aging. For example, it has been shown to inhibit the expression

Protein Name: MicroRNA 636

The "MIR636 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR636 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR637 | MIR638 | MIR639 | MIR640 | MIR641 | MIR642A | MIR642B | MIR643 | MIR644A | MIR645 | MIR646 | MIR646HG | MIR647 | MIR648 | MIR649 | MIR6499 | MIR650 | MIR6500 | MIR6501 | MIR6502 | MIR6503 | MIR6504 | MIR6505 | MIR6506 | MIR6507 | MIR6508 | MIR6509 | MIR651 | MIR6510 | MIR6511A1 | MIR6511A2 | MIR6511A3 | MIR6511A4 | MIR6511B1 | MIR6511B2 | MIR6512 | MIR6513 | MIR6514 | MIR6515 | MIR6516 | MIR652 | MIR653 | MIR654 | MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755